Примери за използване на Applicant submitted на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The Applicant submitted an additional validation study.
To support the application, the Applicant submitted one clinical study in adults.
The applicant submitted its observations on the applications to intervene on 10 January 2007.
In response to that question, the applicant submitted calculations made using Cocomo2 software.
The applicant submitted a scientific report on Porcine Respiratory Disease Complex(PRDC).
Хората също превеждат
By document lodged at the Court Registry on 30 November 2015, the applicant submitted further evidence.
On 12 September 1996 the applicant submitted to the District Prosecutor's Office another request for release.
Tobramycin has been used for several years to treat P. aeruginosa infection in patients with cystic fibrosis and the applicant submitted data from the literature to support the use of Vantobra.
On 1 April 1998 the applicant submitted through the District Prosecutor's Office a third appeal against his detention on remand.
In August 2009, in accordance with the procedure laid down by Security Council Resolution 1730(2006), the applicant submitted a request for the deletion of his name from the Sanctions Committee's list.
In 2011, the Applicant submitted 22 complaints against the Defendant before the Irish Data Protection Commissioner.
Further assessment was required for algae, hence the applicant submitted advanced models for PECs in surfacewater(FOCUS).
The applicant submitted an application for a decentralised procedure for Nuflor Swine Once 450 mg/ml solution for injection.
By document lodged at the Court Registry on 4 March 2014, the applicant submitted its observations on the statements in intervention of FagorBrandt and the French Republic.
The Applicant submitted data from study PK KB-036, which evaluates the PK profile of Hepatitis B.
By letter received at the Registry of the Tribunal on 25 November 2009 the applicant submitted his comments on the impact of Mr Braun-Neumann's death on the present case.
The applicant submitted an application for a decentralised procedure for Melosolute 40 mg/ml solution for injection for cattle, pigs and horses.
On 20 December 2007 and 7 January 2008 respectively, at the request of the Court of First Instance, the Parliament and the applicant submitted their observations on a possible joinder of Cases T-383/06 and T-71/07.
On 9 April 1998 the applicant submitted a renewed bail application mainly on the ground of his ill health.
In the absence of a definitive response to his confirmatory application in procedure Gestdem 2012/3258, the applicant submitted a new application for access to EPSO on 28 December 2012(procedure Gestdem 2013/0068).
Following that letter, the applicant submitted on 22 November 2006 a new request for the balance of the days of leave for 2004 to be carried over;
A certificate issued(free of charge) by the tax inspector of the applicant's domicile or permanent residence,stating that in the last three years the applicant submitted an income tax declaration, or a declaration for any other direct tax, and that after examination the declaration was approved; and.
On 19 May 2015, the applicant submitted a corrected undertaking invoice with a reference to Implementing Decision 2013/707.
A certificate issued(free of charge) by the tax inspector of the applicant's domicile or permanent residence,stating that in the last three years the applicant submitted an income tax declaration, or a declaration for any other direct tax, and that after examination the declaration was approved; and.
Initially, the Applicant submitted the data comparing the adverse events without any statistical analysis and a statistical comparison was requested.
The Marketing Authorisation Holders and Applicant submitted written responses and the clock was restarted on 14 March 2008.
The applicant submitted an application for a decentralised procedure for Florgane 300 mg/ml suspension for injection for cattle and pigs and associated names.
By a communication dated 30 June 2003, the applicant submitted additional documents to prove the distinctive character acquired through use of the first contested mark.
The applicant submitted data from a main study involving 50 patients with Cushing's syndrome who had diabetes and/or high blood pressure, two common features of the condition.
The Commission and the applicant submitted observations on the admissibility of the application to intervene, on 19 January and 2 February 2011, respectively.